297 related articles for article (PubMed ID: 35594502)
1. Novel Therapies in Gynecologic Cancer.
Bejar FG; Oaknin A; Williamson C; Mayadev J; Peters PN; Secord AA; Wield AM; Coffman LG
Am Soc Clin Oncol Educ Book; 2022 Apr; 42():1-17. PubMed ID: 35594502
[TBL] [Abstract][Full Text] [Related]
2. Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
Shim SH; Lee JY; Lee YY; Park JY; Lee YJ; Kim SI; Han GH; Yang EJ; Noh JJ; Yim GW; Son JH; Kim NK; Kim TH; Kong TW; Choi YJ; Cho A; Lim H; Jang EB; Cho HW; Suh DH
J Gynecol Oncol; 2024 Mar; 35(2):e66. PubMed ID: 38330382
[TBL] [Abstract][Full Text] [Related]
3. mTOR inhibitors and their clinical application in cervical, endometrial and ovarian cancers: a critical review.
Husseinzadeh N; Husseinzadeh HD
Gynecol Oncol; 2014 May; 133(2):375-81. PubMed ID: 24556063
[TBL] [Abstract][Full Text] [Related]
4. Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers.
Wolford JE; Ferrigni E; Margul D; Herzog TJ
Curr Oncol Rep; 2022 Jul; 24(7):889-904. PubMed ID: 35347591
[TBL] [Abstract][Full Text] [Related]
5. The Epigenetic Landscape in the Treatment of Gynecologic Malignancies.
Eskander RN
Am Soc Clin Oncol Educ Book; 2018 May; 38():480-487. PubMed ID: 30231335
[TBL] [Abstract][Full Text] [Related]
6. Optimizing immunotherapy for gynecologic cancers.
Rubinstein MM; Makker V
Curr Opin Obstet Gynecol; 2020 Feb; 32(1):1-8. PubMed ID: 31833942
[TBL] [Abstract][Full Text] [Related]
7. Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers.
Muggia FM
Semin Oncol; 2004 Dec; 31(6 Suppl 14):17-24. PubMed ID: 15726530
[TBL] [Abstract][Full Text] [Related]
8. Gynecologic malignancies in older women.
Mirhashemi R; Nieves-Neira W; Averette HE
Oncology (Williston Park); 2001 May; 15(5):580-6; discussion 592-4, 597-8. PubMed ID: 11396354
[TBL] [Abstract][Full Text] [Related]
9. Fertility-sparing options for patients with gynecologic malignancies.
Leitao MM; Chi DS
Oncologist; 2005 Sep; 10(8):613-22. PubMed ID: 16177285
[TBL] [Abstract][Full Text] [Related]
10. Gynecologic cancers.
Boente MP; Schilder R; Ozols RF
Cancer Chemother Biol Response Modif; 1997; 17():536-61. PubMed ID: 9551230
[TBL] [Abstract][Full Text] [Related]
11. The evolving landscape of antibody-drug conjugates in gynecologic cancers.
Tolcher A; Hamilton E; Coleman RL
Cancer Treat Rev; 2023 May; 116():102546. PubMed ID: 37023499
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Efficacy and Adverse Events After Second Immunotherapy Exposure in Endometrial and Cervical Carcinoma.
Morton M; Marcu I; Levine M; Cosgrove C; Backes F; O'Malley D; Chambers L
Obstet Gynecol; 2023 Aug; 142(2):360-363. PubMed ID: 37411031
[TBL] [Abstract][Full Text] [Related]
13. Gynecologic malignancies.
Schaebler DL; Schilder RJ; Young RC
Cancer Chemother Biol Response Modif; 1994; 15():555-80. PubMed ID: 7779599
[No Abstract] [Full Text] [Related]
14. Immuno-oncology for Gynecologic Malignancies.
How J; Patel A; Jazaeri A
Adv Exp Med Biol; 2020; 1244():149-182. PubMed ID: 32301014
[TBL] [Abstract][Full Text] [Related]
15. Major clinical research advances in gynecologic cancer in 2015.
Suh DH; Kim M; Kim HJ; Lee KH; Kim JW
J Gynecol Oncol; 2016 Nov; 27(6):e53. PubMed ID: 27775259
[TBL] [Abstract][Full Text] [Related]
16. Updates in the Use of Targeted Therapies for Gynecologic Cancers.
Cantillo E; Blanc-Durand F; Leary A; Slomovitz BM; Fuh K; Washington C
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e438582. PubMed ID: 38788185
[TBL] [Abstract][Full Text] [Related]
17. Genomic-Based Therapy of Gynecologic Malignancies.
Markman M
Acta Med Acad; 2019 Apr; 48(1):84-89. PubMed ID: 31264436
[TBL] [Abstract][Full Text] [Related]
18. [Minimally invasive treatment of gynecologic cancers].
Ichikawa Y; Yoshikawa H
Gan To Kagaku Ryoho; 2001 Aug; 28(8):1090-3. PubMed ID: 11525023
[TBL] [Abstract][Full Text] [Related]
19. Rational study endpoints in anti-neoplastic agent regulatory approval trials in the gynecologic malignancies.
Markman M
Womens Health (Lond); 2016 Jul; 12(4):396-9. PubMed ID: 27638892
[TBL] [Abstract][Full Text] [Related]
20. Integrating antibody drug conjugates in the management of gynecologic cancers.
Chelariu-Raicu A; Mahner S; Moore KN; Lorusso D; Coleman RL
Int J Gynecol Cancer; 2023 Mar; 33(3):420-429. PubMed ID: 36878560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
